| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $1.18M | $1.36M | $1.09M | $187.41K | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $305.44K | $277.95K | $290.52K | $367.43K | $548.25K |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | $0.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $878.88K | $1.08M | $796.27K | -$180.02K | -$548.25K |
| EPS (basic) | 0.7400 | 1.0200 | 0.7200 | -0.1400 | -0.3000 |
| EPS (diluted) | 0.7400 | 1.0200 | 0.7200 | -0.1400 | -0.3000 |
| Shares (diluted) | $1.19M | $1.06M | $1.10M | $1.33M | $1.82M |